arrow
G

Gangadhara R. Sareddy

university of texas health san antonio
H指数:31
被引数:2,836

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide

PRMT5抑制使胶质母细胞瘤肿瘤模型对替莫唑胺更敏感

2025-11-010
OAAI
Ligand-receptor interactions induce and mediate regulatory functions of BATF3+ B cells

配体-受体相互作用诱导并介导BATF3+ B细胞的调控功能

2025-10-080
PRE
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis
2024-05-243
OAAI
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (vol 3, pg 866, 2022)
2024-05-200
OAAI
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer
2023-10-0110
OAAI
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma
2023-01-1813
OA
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER plus Breast Cancer
2022-08-118
OA
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress
2022-06-0214
OAAI
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer
2022-01-0118
OAAI
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
2021-10-2917
OAAI
LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
2021-08-1621
OAAI